Literature DB >> 9632883

RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.

N A Naryshkin1, M J Gait, M G Ivanovskaya.   

Abstract

Viral transcription factor Tat is a small nuclear protein containing a large number of basic amino acids. The tat gene consists of two exons but only the first encoding 72-amino acid polypeptide is necessary for protein activity. Since the second exon is poorly conservative the total number of amino acids among Tat proteins from different strains of HIV-1 varies from 86 to 130. Tat protein acts as trans-activator of HIV genome transcription. It is absolutely required for viral functioning. Tat increases processivity of RNA-polymerase II by abolition of transcription blockade, which appears after polycondensation of the first 60-70 nucleotides of either HIV mRNA, i.e., it acts as antiterminator. For manifestation of its activity Tat specifically binds to the double stranded RNA fragment called TAR which is located at the 5'-terminus of all HIV mRNAs. The TAR structure contains a hairpin and a side loop. The Tat-binding region includes only a site of the loop; manifestation of Tat activity in vivo requires the full TAR and additional cellular co-factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632883

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  2 in total

1.  Effect of single-residue bulges on RNA double-helical structures: crystallographic database analysis and molecular dynamics simulation studies.

Authors:  Angana Ray; Ankita Agarwal; Dhananjay Bhattacharyya
Journal:  J Mol Model       Date:  2017-10-14       Impact factor: 1.810

2.  Modeling the Function of TATA Box Binding Protein in Transcriptional Changes Induced by HIV-1 Tat in Innate Immune Cells and the Effect of Methamphetamine Exposure.

Authors:  Ryan Tjitro; Lee A Campbell; Liana Basova; Jessica Johnson; Julia A Najera; Alexander Lindsey; Maria Cecilia Garibaldi Marcondes
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.